Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Rosetta Inpharmatics: Decoding genomics

The next 10 years will see an exponential increase in the amount of expression data available to analyze gene function. While it is now straightforward to generate the data, what is more problematic is the best way to sift through it to get useful correlations between gene expression and chemical compound activity. Rosetta Inpharmatics Inc. believes it has technology that addresses both concerns.

The company's approach is similar to using a "reporter" gene to monitor the activity of a single

Read the full 793 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE